# Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery

> **NCT03006380** · PHASE2 · UNKNOWN · sponsor: **Ain Shams Maternity Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** oxytocin

## Key facts

- **NCT ID:** NCT03006380
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-09
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2017-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006380, "Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03006380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
